Atomoxetina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atomoxetina" in Italian language version.

refsWebsite

Global rank Italian rank

8nih.gov

4^th place

9^th place

6oadoi.org

799^th place

22^nd place

6doi.org

2^nd place

7^th place

1web.archive.org

1^st place

doi.org

dx.doi.org

M. Stuhec, V. Svab, Atomoxetine-induced life-threatening long QT syndrome., in Ir J Med Sci, febbraio 2013, DOI:10.1007/s11845-013-0925-y, PMID 23420381.
J. Kashani, AM. Ruha, Isolated atomoxetine overdose resulting in seizure., in J Emerg Med, vol. 32, n. 2, febbraio 2007, pp. 175-8, DOI:10.1016/j.jemermed.2006.05.048, PMID 17307628.
JF. Wernicke, KC. Holdridge; L. Jin; T. Edison; S. Zhang; ME. Bangs; AJ. Allen; S. Ball; D. Dunn, Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine., in Dev Med Child Neurol, vol. 49, n. 7, luglio 2007, pp. 498-502, DOI:10.1111/j.1469-8749.2007.00498.x, PMID 17593120.
AT. McAfee, J. Landon; M. Jones; ME. Bangs; N. Acharya; K. Hornbuckle; J. Wong, A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications., in Pharmacoepidemiol Drug Saf, vol. 22, n. 4, aprile 2013, pp. 386-93, DOI:10.1002/pds.3390, PMID 23280590.
A. Aggarwal, G. Kulkarni; S. Jahan, Potential serious adverse interactions between linezolid and atomoxetine., in J Child Adolesc Psychopharmacol, vol. 22, n. 5, ottobre 2012, p. 405, DOI:10.1089/cap.2012.0040, PMID 23083031.
C. Loghin, H. Haber; CM. Beasley; PA. Kothare; L. Kauffman; J. April; L. Jin; AJ. Allen; MI. Mitchell, Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers., in Br J Clin Pharmacol, vol. 75, n. 2, febbraio 2013, pp. 538-49, DOI:10.1111/j.1365-2125.2012.04382.x, PMID 22803597.

nih.gov

ncbi.nlm.nih.gov

M. Stuhec, V. Svab, Atomoxetine-induced life-threatening long QT syndrome., in Ir J Med Sci, febbraio 2013, DOI:10.1007/s11845-013-0925-y, PMID 23420381.
S. Sawant, SR. Daviss, Seizures and prolonged QTc with atomoxetine overdose., in Am J Psychiatry, vol. 161, n. 4, aprile 2004, p. 757, PMID 15056530.
J. Kashani, AM. Ruha, Isolated atomoxetine overdose resulting in seizure., in J Emerg Med, vol. 32, n. 2, febbraio 2007, pp. 175-8, DOI:10.1016/j.jemermed.2006.05.048, PMID 17307628.
JF. Wernicke, KC. Holdridge; L. Jin; T. Edison; S. Zhang; ME. Bangs; AJ. Allen; S. Ball; D. Dunn, Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine., in Dev Med Child Neurol, vol. 49, n. 7, luglio 2007, pp. 498-502, DOI:10.1111/j.1469-8749.2007.00498.x, PMID 17593120.
AT. McAfee, KC. Holdridge; CB. Johannes; K. Hornbuckle; AM. Walker, The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database., in Curr Drug Saf, vol. 3, n. 2, maggio 2008, pp. 123-31, PMID 18690990.
AT. McAfee, J. Landon; M. Jones; ME. Bangs; N. Acharya; K. Hornbuckle; J. Wong, A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications., in Pharmacoepidemiol Drug Saf, vol. 22, n. 4, aprile 2013, pp. 386-93, DOI:10.1002/pds.3390, PMID 23280590.
A. Aggarwal, G. Kulkarni; S. Jahan, Potential serious adverse interactions between linezolid and atomoxetine., in J Child Adolesc Psychopharmacol, vol. 22, n. 5, ottobre 2012, p. 405, DOI:10.1089/cap.2012.0040, PMID 23083031.
C. Loghin, H. Haber; CM. Beasley; PA. Kothare; L. Kauffman; J. April; L. Jin; AJ. Allen; MI. Mitchell, Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers., in Br J Clin Pharmacol, vol. 75, n. 2, febbraio 2013, pp. 538-49, DOI:10.1111/j.1365-2125.2012.04382.x, PMID 22803597.

oadoi.org

M. Stuhec, V. Svab, Atomoxetine-induced life-threatening long QT syndrome., in Ir J Med Sci, febbraio 2013, DOI:10.1007/s11845-013-0925-y, PMID 23420381.
J. Kashani, AM. Ruha, Isolated atomoxetine overdose resulting in seizure., in J Emerg Med, vol. 32, n. 2, febbraio 2007, pp. 175-8, DOI:10.1016/j.jemermed.2006.05.048, PMID 17307628.
JF. Wernicke, KC. Holdridge; L. Jin; T. Edison; S. Zhang; ME. Bangs; AJ. Allen; S. Ball; D. Dunn, Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine., in Dev Med Child Neurol, vol. 49, n. 7, luglio 2007, pp. 498-502, DOI:10.1111/j.1469-8749.2007.00498.x, PMID 17593120.
AT. McAfee, J. Landon; M. Jones; ME. Bangs; N. Acharya; K. Hornbuckle; J. Wong, A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications., in Pharmacoepidemiol Drug Saf, vol. 22, n. 4, aprile 2013, pp. 386-93, DOI:10.1002/pds.3390, PMID 23280590.
A. Aggarwal, G. Kulkarni; S. Jahan, Potential serious adverse interactions between linezolid and atomoxetine., in J Child Adolesc Psychopharmacol, vol. 22, n. 5, ottobre 2012, p. 405, DOI:10.1089/cap.2012.0040, PMID 23083031.
C. Loghin, H. Haber; CM. Beasley; PA. Kothare; L. Kauffman; J. April; L. Jin; AJ. Allen; MI. Mitchell, Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers., in Br J Clin Pharmacol, vol. 75, n. 2, febbraio 2013, pp. 538-49, DOI:10.1111/j.1365-2125.2012.04382.x, PMID 22803597.

web.archive.org

Pharmamedix, Atomoxetina: Interazioni, su pharmamedix.com. URL consultato il 28 agosto 2014 (archiviato dall'url originale il 29 luglio 2014).